SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against Clifton Bancorp Inc.
Feb 19, 2018 02:00 am UTC| Business
WILMINGTON, Del., Feb. 18, 2018 -- Rigrodsky Long, P.A.: Rigrodsky Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of New Jersey on behalf of...
Growth Energy Congratulates Austin Dillon on Historic Daytona 500 Win
Feb 19, 2018 01:53 am UTC| Business
Washington, D.C., Feb. 18, 2018 -- Washington, DC — On Sunday evening, Feb. 18, American Ethanol driver and spokesperson Austin Dillon secured a historic Monster Energy NASCAR Cup Series win, driving the legendary...
BEST Background Check Site Comparison Announced by Background Check Solutions
Feb 19, 2018 00:18 am UTC| Business
SAN DIEGO, Feb. 18, 2018 -- “Of the hundreds of existing online background check sites, only a handful services provide accurate results, and therefore can be endorsed,” states Natalie Nathan, a spokesperson for...
Feb 18, 2018 23:00 pm UTC| Business
LA JOLLA, Calif., Feb. 18, 2018 -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced...
Adhesive Bra Brand Launches Eco-Friendly New Design With Essential Oils
Feb 18, 2018 14:00 pm UTC| Business
SHENZHEN, China, Feb. 18, 2018 -- If there’s one brand that understands how to make a great adhesive bra, it’s Kissbobo. In 2016 they launched their first pure-silicone bra which went on to achieve international...
Feb 17, 2018 23:30 pm UTC| Business
SAN DIEGO, Feb. 17, 2018 -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients...
AnaptysBio Presents Updated Data from ANB020 Phase 2a Atopic Dermatitis Trial at AAD Annual Meeting
Feb 17, 2018 22:00 pm UTC| Business
SAN DIEGO, Feb. 17, 2018 -- AnaptysBio, Inc. (Nasdaq:ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced...